We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.9B
AUM Growth
+$1.9B
Cap. Flow
+$442M
Cap. Flow %
3.42%
Top 10 Hldgs %
34.89%
Holding
1,323
New
145
Increased
499
Reduced
420
Closed
63

Top Buys

Rank Stock Value
1
COLD icon
Americold
COLD
+$166M
2
OHI icon
Omega Healthcare
OHI
+$102M
3
SUI icon
Sun Communities
SUI
+$98.2M
4
AIRC
Apartment Income REIT Corp.
AIRC
+$97.3M
5
DOC icon
Healthpeak Properties
DOC
+$93.5M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$261M
2
PLD icon
Prologis
PLD
+$67.9M
3
KRC icon
Kilroy Realty
KRC
+$67.2M
4
WELL icon
Welltower
WELL
+$62.1M
5
STOR
STORE Capital Corporation
STOR
+$56.9M

Sector Composition

Rank Sector Weight
1 Real Estate 60.68%
2 Technology 7.51%
3 Communication Services 3.68%
4 Healthcare 3.56%
5 Consumer Discretionary 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KURA icon
1076
Kura Oncology
KURA
$815M
$3K ﹤0.01%
107
-181
-63% -$6.36K
LGND icon
1077
Ligand Pharmaceuticals
LGND
$5.8B
$3K ﹤0.01%
48
-99
-67% -$5.64K
MDGL icon
1078
Madrigal Pharmaceuticals
MDGL
$12.5B
$3K ﹤0.01%
+29
New +$3.54K
MRSN
1079
DELISTED
Mersana Therapeutics
MRSN
$3K ﹤0.01%
+5
New +$2.78K
MYGN icon
1080
Myriad Genetics
MYGN
$485M
$3K ﹤0.01%
141
-279
-66% -$4.5K
OCUL icon
1081
Ocular Therapeutix
OCUL
$1.85B
$3K ﹤0.01%
+134
New +$1.99K
PCVX icon
1082
Vaxcyte
PCVX
$7.66B
$3K ﹤0.01%
+96
New +$3.57K
PSNL icon
1083
Personalis
PSNL
$1.26B
$3K ﹤0.01%
73
-103
-59% -$3.11K
QURE icon
1084
uniQure
QURE
$2.81B
$3K ﹤0.01%
84
-162
-66% -$6.83K
REPL icon
1085
Replimune Group
REPL
$447M
$3K ﹤0.01%
+86
New +$3.58K
RGNX icon
1086
Regenxbio
RGNX
$622M
$3K ﹤0.01%
70
-138
-66% -$4.82K
SRRK icon
1087
Scholar Rock
SRRK
$5.88B
$3K ﹤0.01%
63
-105
-63% -$3.81K
TVTX icon
1088
Travere Therapeutics
TVTX
$5.22B
$3K ﹤0.01%
96
-167
-63% -$3.9K
FMTX
1089
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$3K ﹤0.01%
+77
New +$3.35K
ENDP
1090
DELISTED
Endo International plc
ENDP
$3K ﹤0.01%
433
-847
-66% -$4.42K
DRNA
1091
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$3K ﹤0.01%
141
-281
-67% -$6.19K
TBIO
1092
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$3K ﹤0.01%
140
-203
-59% -$3.63K
CNST
1093
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$3K ﹤0.01%
+89
New +$2.24K
ADVM
1094
DELISTED
Adverum Biotechnologies
ADVM
$2K ﹤0.01%
18
-26
-59% -$3.22K
AKRO
1095
DELISTED
Akero Therapeutics
AKRO
$2K ﹤0.01%
65
-96
-60% -$2.67K
ALEC icon
1096
Alector
ALEC
$170M
$2K ﹤0.01%
149
-289
-66% -$3.59K
AMPH icon
1097
Amphastar Pharmaceuticals
AMPH
$909M
$2K ﹤0.01%
89
-176
-66% -$3.42K
ANNX icon
1098
Annexon
ANNX
$793M
$2K ﹤0.01%
+72
New +$1.85K
ARCT icon
1099
Arcturus Therapeutics
ARCT
$163M
$2K ﹤0.01%
+46
New +$3.12K
ARQT icon
1100
Arcutis Biotherapeutics
ARQT
$3.5B
$2K ﹤0.01%
+82
New +$2.01K
42 43
44
45 46

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Daiwa Securities Group's Q4 2020 Portfolio in Review

As of Q4 2020, Daiwa Securities Group held 1,323 positions worth $12.9B, up 17% from $11B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $442M of net new capital in Q4 2020, opening 145 new positions and adding to 499 existing holdings. Its largest new stake was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, down from 62% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Equinix, an estimated $261M trimmed.

  • Daiwa Securities Group's largest Q4 2020 buy was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.
  • Daiwa Securities Group added most to Americold in Q4 2020, an estimated $166M increase.
  • Daiwa Securities Group's biggest Q4 2020 reduction was Equinix, cutting an estimated $261M.
  • Daiwa Securities Group fully exited NextEra Energy, Inc. 6.219% Corporate Units in Q4 2020, selling an estimated $16.6M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $12.9B portfolio in Q4 2020.
  • Daiwa Securities Group opened 145 new positions and closed 63 in Q4 2020.
  • Daiwa Securities Group's portfolio value rose 17% quarter-over-quarter to $12.9B.

Based on Daiwa Securities Group's 13F filing for Q4 2020, filed 4 Feb 2021.